APDA’s New Diversity-Focused Grant Invigorates Inclusion in Parkinson’s Research

As part of our efforts to support novel and innovative...see more research, your generosity has made it possible for the American Parkinson Disease Association (APDA) to grant $1.4 million to support critical Parkinson’s disease (PD) research for the 2020-2021 funding year ― one of the grants awarded […]

Read More

Sage Therapeutics sponsored trial for Parkinson’s Disease Mild Cognitive Impairment (PD-MCI)

Sage Therapeutics sponsored trial for Parkinson’s Disease Mild...see more Cognitive Impairment (PD-MCI): Research study for adults ages 50 to 75 years old who have been diagnosed with PD-MCI. The purpose of this study is to evaluate the safety and tolerability of an investigational medication. Participants must […]

Read More